Genotypic and Phenotypic Correlates of the HIV Type 1envGene Evolution in Infected Children with Discordant Response to Antiretroviral Therapy
- 1 December 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 20 (12) , 1306-1313
- https://doi.org/10.1089/aid.2004.20.1306
Abstract
The genotypic–phenotypic correlates of human immunodeficiency virus type 1 (HIV-1) env gene evolution were investigated in samples from eight infected children under antiretroviral therapy (ART) and virological failure. Evolution of the gp120 C2–V5 env sequence was demonstrated in all subjects but one by sequence analysis of the replicating plasma virus collected at baseline and 12–15 months after ART initiation. The analysis of the host's selective pressure showed that in four subjects, the ratio of nonsynonymous to synonymous amino acid substitutions was higher in the V3 sequences than in the C2–V5 region ([K a/K s]V3/[K a/K s]C2–V5 >1.0). Interestingly, this feature was observed only in subjects (four of five) showing an increase in T cell receptor rearrangement excision circle (TREC)-bearing cells and in CD4+ T-lymphocytes despite persistent viremia (discordant therapeutic response) (p = 0.02), thus suggesting that the V3 loop is a target of the immune reconstitution under ART. Using phenotypic analysis of recombinant viruses expressing exogenous V3 sequences, a reverse shift from CXCR4-tropic to CCR5-tropic variants was demonstrated in two of the four subjects, further indicating that the host's selective pressure sharply forces the V3 evolution of replicating variants. The data indicate that a complex HIV-1–host interplay occurs in children receiving antiretroviral treatments and suggest that the recovery of thymic function places a selective constraint on the viral V3 loop.Keywords
This publication has 26 references indexed in Scilit:
- The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 InfectionAIDS Research and Human Retroviruses, 2004
- Processivity and drug-dependence of HIV-1 proteaseAIDS, 2003
- A New Perspective on V3 Phenotype PredictionAIDS Research and Human Retroviruses, 2003
- Increased Thymic Output after Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus Type 1–Infected Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 TrialThe Journal of Infectious Diseases, 2002
- N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular TropismJournal of Virology, 2001
- Evaluation of T Cell Receptor Gene Rearrangement Excision Circles after Antiretroviral Therapy in Children Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 2001
- Effect of HIV on Thymic Function before and after Antiretroviral Therapy in ChildrenThe Journal of Infectious Diseases, 2000
- Rare mutations in a domain crucial for V3-loopstructure prevail in replicating HIV from long-term non-progressorsAIDS, 1998
- RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVALAnnual Review of Microbiology, 1997
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsThe Journal of Experimental Medicine, 1997